Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGRNASDAQ:BIOLNASDAQ:HSDTNASDAQ:NAYA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGRAvinger$0.47$0.47$0.36▼$3.99$1.57M1.091.11 million shsN/ABIOLBIOLASE$0.01+8.0%$0.01$0.02▼$1.94$451K0.672.58 million shs27,099 shsHSDTHelius Medical Technologies$4.31+0.9%$5.10$3.32▼$25.20$1.76M1.1189,077 shs7,047 shsNAYANAYA Biosciences$1.98-7.0%$2.22$1.38▼$17.04$1.32M2.0353,151 shs264,562 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGRAvinger0.00%0.00%0.00%-20.74%-88.09%BIOLBIOLASE+8.00%+64.63%-3.57%+50.00%-91.23%HSDTHelius Medical Technologies+0.94%+3.36%-4.13%-44.04%-81.58%NAYANAYA Biosciences-7.04%+4.21%-12.39%-54.17%+197,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVGRAvingerN/AN/AN/AN/AN/AN/AN/AN/ABIOLBIOLASE0.7885 of 5 stars3.30.00.00.00.60.00.0HSDTHelius Medical Technologies0.691 of 5 stars0.05.00.00.02.80.00.0NAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGRAvinger 0.00N/AN/AN/ABIOLBIOLASE 2.67Moderate Buy$1.208,788.89% UpsideHSDTHelius Medical Technologies 2.00HoldN/AN/ANAYANAYA Biosciences 3.00Buy$24.001,112.12% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGRAvinger$7.26M0.22N/AN/A($4.53) per share-0.10BIOLBIOLASE$48.83M0.01N/AN/A($0.07) per share-0.19HSDTHelius Medical Technologies$434K4.06N/AN/A$3.32 per share1.30NAYANAYA Biosciences$6.23M0.21N/AN/A($2.06) per share-0.96Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGRAvinger-$18.32M-$11.06N/AN/AN/A-261.06%-5,527.11%-123.25%N/ABIOLBIOLASE-$20.63M-$14.94N/A∞N/A-41.65%-1,782.73%-55.31%N/AHSDTHelius Medical Technologies-$8.85M-$47.53N/A∞N/A-1,764.74%-244.82%-127.10%N/ANAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%6/29/2025 (Estimated)Latest BIOL, HSDT, AVGR, and NAYA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/1/2025Q1 2025HSDTHelius Medical Technologies-$0.58-$0.51+$0.07-$0.51N/A$0.05 million3/25/2025Q4 2024HSDTHelius Medical Technologies-$14.10-$15.45-$1.35-$1.03$0.10 million$0.15 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVGRAvingerN/AN/AN/AN/AN/ABIOLBIOLASEN/AN/AN/AN/AN/AHSDTHelius Medical TechnologiesN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGRAvingerN/A1.210.81BIOLBIOLASEN/A0.710.36HSDTHelius Medical TechnologiesN/A3.613.10NAYANAYA BiosciencesN/A0.230.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGRAvinger18.30%BIOLBIOLASE8.79%HSDTHelius Medical Technologies18.63%NAYANAYA Biosciences12.02%Insider OwnershipCompanyInsider OwnershipAVGRAvinger42.80%BIOLBIOLASE0.27%HSDTHelius Medical Technologies5.10%NAYANAYA Biosciences1.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGRAvinger703.31 million1.89 millionNot OptionableBIOLBIOLASE16033.41 million33.32 millionNot OptionableHSDTHelius Medical Technologies30409,0003.54 millionNot OptionableNAYANAYA Biosciences10666,0004.40 millionN/ABIOL, HSDT, AVGR, and NAYA HeadlinesRecent News About These CompaniesINVO Fertility, Inc.: INVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"April 29, 2025 | finanznachrichten.deINVO Fertility Inc.April 29, 2025 | barrons.comINVO Fertility announces new Nasdaq trading symbolApril 25, 2025 | markets.businessinsider.comMaxim Group downgrades NAYA Biosciences (NAYA) to a HoldApril 25, 2025 | markets.businessinsider.comINVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”April 24, 2025 | globenewswire.comNAYA Biosciences IncApril 18, 2025 | morningstar.comNAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”April 14, 2025 | globenewswire.comNAYA BIOSCIENCES Earnings Preview: Recent $NAYA Insider Trading, Hedge Fund Activity, and MoreApril 14, 2025 | nasdaq.comNAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025March 13, 2025 | globenewswire.comNAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility TreatmentFebruary 25, 2025 | globenewswire.comNAYA Biosciences Announces Nomination of New Board MembersFebruary 19, 2025 | globenewswire.comNAYA Stock Hits 52-Week Low at $0.35 Amid Market ChallengesFebruary 12, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIOL, HSDT, AVGR, and NAYA Company DescriptionsAvinger NASDAQ:AVGR$0.47 0.00 (0.00%) As of 05/13/2025Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.BIOLASE NASDAQ:BIOL$0.01 +0.00 (+8.00%) As of 05/13/2025BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.Helius Medical Technologies NASDAQ:HSDT$4.31 +0.04 (+0.94%) As of 05/14/2025 03:14 PM EasternHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.NAYA Biosciences NASDAQ:NAYA$1.98 -0.15 (-7.04%) As of 05/13/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start AMD’s AI-Powered Stock Price Rally Just Shifted Gears Oklo Reaches Critical Mass, Atomic Upside Still Available Is Verizon a Buy? Q1 Results and Solid Dividend Make Bullish Case Carnival's Comeback: Is the Stock Set for a Profitable Journey? 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears U.S. Regulators Target CrowdStrike: Is It a Signal or Noise? Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
